About this trial
Chest wall tumors should be completely resection as much as possible while malignant chest wall tumors should be extensively resection. If not completely resection, it will recur in the short time and affect the patient's survival. At present, the surgical resection range mainly relies on preoperative imaging examination and the experience of the surgeon. It lacks precise guidance. This can easily lead to incomplete resection. In addition, the reconstruction materials required for reconstruct the excised chest wall defection are often generated in a standardized manner, lacking intraoperative adjustability. To address this clinical issue, we plan to carry out the research on the application of artificial Intelligence (AI) assisted chest wall tumor resection combined with personalized 3D preformed chest wall defection reconstruction system in chest wall tumor surgery.
Eligibility criteria
Qualifiers
18-70 years old, male or female not limited
Anesthesia ASA score I-II
Malignant tumor of soft tissue in the chest
Malignant tumors of ribs, rib cartilage, and sternum
Disqualifiers
Patients with distant metastasis detected during preoperative examination
Inoperable tumor
During the examination, it was discovered that the patient had another type of malignant tumor present
ECOG 4
Trial design
Treatments tested in this trial
- Chest wall tumor resection by the artificial intelgent assistent
Treatment groups
Locations
Sponsors and collaborators
Wu Weiming
Lead sponsor
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Sponsor institution